share_log

盛禾生物-B(02898.HK)将于8月30日举行董事会会议以审批中期业绩

Shenghe Biotech-B (02898.HK) will hold a board of directors meeting on August 30th to approve the interim performance.

Gelonghui Finance ·  Aug 20 05:33

Shenghe Bio-B (02898.HK) announced that the company will hold a board of directors meeting on August 30, 2024 to approve the interim performance of the company and its subsidiaries for the six months ending June 30, 2024, as well as its publication.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment